Ultralife Corporation (ULBI)
Official siteINDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ
Market Cap: $261.30M
Last updated: Nov 17, 2026 at 4:10 PM ET
Ultralife Corporation (ULBI) Stock Chart
Ultralife (ULBI) has a latest price of $15.67 on Nov 17, 2026, 1.0% below its 52-week high of $15.83. Its price rose 181.8% over the past 12 months. The month-end price rose 281.0% over the 10 years through Oct 2026, a compound annual rate of 14.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $15.62 in Oct 2026 and its lowest $3.86 in Dec 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ULBI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ULBI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 123.9%, and over 6 months it rose 161.2%. The month-end price rose 110.5% over the 3 years through Oct 2026, a compound annual rate of 28.2%.
| Period | Change |
|---|---|
| 1 month | +158.6% |
| 3 months | +123.9% |
| 6 months | +161.2% |
| 12 months | +181.8% |
| 12 months, with dividends | +181.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +110.5% | +28.2% |
| 5 years | +149.5% | +20.1% |
| 10 years | +281.0% | +14.3% |
Price by Year
Its best calendar year was 2023, when the price rose 76.7%, and its weakest was 2022, when it fell 36.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $15.62 | +173.1% |
| 2025 | $5.72 | -23.2% |
| 2024 | $7.45 | +9.2% |
| 2023 | $6.82 | +76.7% |
| 2022 | $3.86 | -36.1% |
| 2021 | $6.04 | -6.6% |
| 2020 | $6.47 | -12.4% |
| 2019 | $7.39 | +9.5% |
| 2018 | $6.75 | +3.1% |
| 2017 | $6.55 | +32.3% |
Trading Range
The price is 75.4% above its 50-day average of $8.94 and 123.1% above its 200-day average of $7.02.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $15.67 | |
| 52-week high | $15.83 | -1.0% |
| 52-week low | $4.90 | +219.8% |
| 50-day average | $8.94 | +75.4% |
| 200-day average | $7.02 | +123.1% |
Price Risk
Over 3 years, its largest fall from a peak was 68.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.04 |
| Largest fall, 1 year | -35.1% |
| Largest fall, 3 years | -68.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ULBI
What is ULBI's 1-year price change?
Ultralife's price rose 181.8% over the past 12 months. With dividends included, the 12-month total return was 181.8%.
What is ULBI's 5-year price change?
Ultralife's month-end price rose 149.5% over the 5 years through Oct 2026, a compound annual rate of 20.1%. These figures leave out dividends.
What is ULBI's 52-week high and low?
Ultralife's 52-week high is $15.83 and its 52-week low is $4.90. Its latest price of $15.67 on Nov 17, 2026 is 1.0% below the high.
What is ULBI's beta?
Ultralife's 1-year beta against the S&P 500 is 1.04, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 35.1%.
Is the ULBI chart free?
Yes. Advanced Charting for ULBI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ULBI pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors, Government Contracts